CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


<
Celgene Corp  (CELG)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Celgene Corp

CELG's Financial Statements and Analysis






Celgene Corp reported IV. Quarter net loss per share of $-0.10 compare to earnings per share of $0.53 in the same quarter a year ago a decrease from $1.21 eps realized in III. Quarter (Sep 30 2017).

Celgene's Revenue rose by % in IV. Quarter (Dec 31 2017) year on year, to $3,483 million and advanced by 5.96 % sequentially.


Celgene is
More on CELG's Income Statement

IV. Quarter
Earnings Per Share Revenues
$ -0.1 $  3,483 Mill
$-0.63     $+503M     +16.86 %
You need to upgrade your Flash Player


       
  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• POMALYST, IMNOVID 41.63% Y/Y,
• azacitidine injection 7.04% Y/Y
   
     
       
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y
   
     


CELG's Segments

CELG's NET INCOME

Celgene's in IV. Quarter recorded net loss of $-2,990 million, compare to net income of $429 million achieved in IV. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $988.00 million in previous quarter.

More on CELG's Growth

Inventories Inventories grew by 8.66 % to $541 million from IV. Quarter a year ago, sequentially inventories rose by 0.74 %. CELG's Cash flow In IV. Quarter company's net cash flow was $1,502 million, capital expenditures fell by 55.12%, to $-103 millions compare to same quarter a year ago and fell by 134.09% from III. Quarter (Sep 30 2017).

More on CELG's Cash flow Statement



Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 6.78 cash per share, on a free-cash flow basis 189.45 % of net earning per share.

Book value fell by -25.95 % sequentially to $8.95 per share.
Tangible Book value fell to $ -8.25 per share from $ -6.32.

Company repurchased 41.70 million shares or 5.12 % in IV. Quarter.
Interest Coverage Ratio was 6.68. Debt Coverage Ratio was 0.35.

More on CELG's Dividends
 Market Capitalization (Millions) 68,950
 Shares Outstanding (Millions) 774
 Total Debt (Millions $) 15,838
 Revenue (TTM) (Millions $) 12,998
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 843
 Capital Exp. (TTM) (Millions $) -279
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012





Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 6.78 cash per share, on a free-cash flow basis 189.45 % of net earning per share.

Book value fell by -25.95 % sequentially to $8.95 per share.
Tangible Book value fell to $ -8.25 per share from $ -6.32.

Company repurchased 41.70 million shares or 5.12 % in IV. Quarter.
Interest Coverage Ratio was 6.68. Debt Coverage Ratio was 0.35.

More on CELG's Dividends
 Market Capitalization (Millions) 68,950
 Shares Outstanding (Millions) 774
 Total Debt (Millions $) 15,838
 Revenue (TTM) (Millions $) 12,998
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 843
 Capital Exp. (TTM) (Millions $) -279
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FSM's Profile

Stock Price

FSM's Financials

Business Description

Fundamentals

Charts & Quotes

FSM's News

Suppliers

FSM's Competitors

Customers & Markets

Economic Indicators

FSM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071